Clinical Trials Industry News More
-
NextPharma Technologies Partners With CARBOGEN AMCIS In Alliance Which Combines Investigational Medicinal Product And Active Pharmaceutical Ingredient Services For Highly Potent Active Pharmaceutical Ingredients
10/8/2009
NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotechnology industries, is pleased to announce that it has entered into an agreement with CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, to provide customers with seamless development services covering highly potent pharmaceutical ingredient (APIs) and Investigational Medicinal Products (IMPs) for clinical trials.
-
Specialist UK Distributor Of Analytical & Life Science Instrumentation
10/8/2009
Benefiting from over 25 years of experience in the analytical instrumentation and life science industry - Dorton Analytical Ltd - a new distribution company serving the UK scientific community was formed on the 1st September, 2009.
-
Vetter Inaugurates Comprehensive Site In Germany
9/29/2009
The comprehensive Ravensburg Vetter South site was officially inaugurated on September 25. The past six years have seen Vetter invest significantly into the site, with a total area of some 80,000 m2 (862,000 ft2), that now includes state-of-the-art facilities for the aseptic filling and packaging of injectable drugs.
-
New Automatic Cell Feeding Station PROcellcare For Life Cell Imaging
9/22/2009
PROdesign GmbH launches the innovative cell feeding station PROcellcare based on a 96 well plate. The System has initially been developed by the licensing partner EMBL (European Molecular Biology Laboratory).
-
Early Results: In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine
9/22/2009
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
-
Edmund Optics Releases New Catalog With Biotech Focus
9/22/2009
Edmund Optics (EO), the premier provider of optical components, has released a catalog featuring product lines of specific interest for researchers and product developers working in the demanding biotech field.
-
Florida Biologix® Announces Manufacturing Agreement With America Stem Cell Inc.
9/22/2009
America Stem Cell and Florida Biologix team up to get an important cancer therapy to the clinic that can potentially making a life-changing difference for patients with blood-related cancers such as Leukemia, Lymphoma and Myeloma.
-
RainDance Technologies And CLC Bio Collaborate To Develop Specialized Software Solutions For Targeted Resequencing
9/18/2009
RainDance Technologies and CLC bio recently announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next-generation DNA sequencing platforms.
-
FDA Approves Vaccines For 2009 H1N1 Influenza Virus
9/17/2009
The U.S. Food and Drug Administration announced recently that it has approved four vaccines against the 2009 H1N1 influenza virus. The vaccines will be distributed nationally after the initial lots become available, which is expected within the next four weeks.
-
Avaxia Biologics Awarded Phase I SBIR Grant To Develop Antibody Therapeutic For Oral Mucositis
9/17/2009
Avaxia Biologics, Inc., a biotechnology company developing oral antibodies for disease targets accessible via the GI tract, announced recently that it has been awarded a Phase I SBIR grant from the National Institute of Dental and Craniofacial Research to support the development of a novel antibody therapeutic for oral mucositis.
This website uses cookies to ensure you get the best experience on our website. Learn more